The type 2 diabetes drug Byetta has had its label changed, according to the Food and Drug Administration in America. The change will reflect a greater than previously thought risk of kidney problems as a result of taking the diabetes drug .
Byetta is also known as Exenatide, and is made by US company Amylin Pharmaceuticals . Byetta hit the news earlier this year with reports of kidney function problems amongst people with diabetes taking the drug. The FDA pointed out that some of these patients already had underlying kidney disease .
A minority of people with diabetes who take Byetta have suffered from haemorrhagic pancreatitis. Byetta is a large-scale diabetes drug, with seven million prescriptions dispensed between April 2005 and September 2008.
The FDA reportedly stated: “Kidney malfunction can result in a build-up of waste products in the blood, leading to serious illness or life-threatening conditions.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…